The global biochips market was valued at $9,037 million in 2017, and is projected to reach $21,419 million by 2025 at a CAGR of 11.2% from 2018 to 2025
Biochips Market by Product (DNA Chip, Protein Chip, Lab-on-a-chip, and Others), Application (Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture, and Others), and End User (Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostics Centers, Academic & Research Institutes, and Others): Global Opportunity Analysis and Industry Forecast, 2018 - 2025
New York, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Biochips Market by Product, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2018 - 2025" - https://www.reportlinker.com/p05663899/?utm_source=GNW
Biochips Market Overview :
Biochip is a miniaturized medical device, which performs several biochemical reactions. This device is a collection of microarrays or micro-test strips that are arranged on the surface of chip, and are meant to perform multiple tests simultaneously. Biochip is extremely small in size ranging from 2 inches to 12 inches. These chips can perform various biotechnology applications such as decoding genes and searching for contaminations in the sample in a few seconds.
The global biochips market was valued at $9,037 million in 2017, and is projected to reach $21,419 million by 2025 at a CAGR of 11.2% from 2018 to 2025. Factors such as rise in prevalence of various life-threatening diseases increases the demand for disease diagnostics, which in turn drives the growth of the global biochips market. Moreover, rise in adoption of personalized medicines and presence of large geriatric population boost the market growth. However, lack of knowledge related to biochips and their high cost of hamper the market growth. Conversely, huge untapped potential in the emerging countries, such as China and India, and rise in R&D investment as well as government funding are expected to offer lucrative opportunities to the market players.
The global biochips market is segmented based on product, application, end user, and region. Depending on product, the market is divided into DNA chip, protein chip, lab-on-a-chip, and others. By application, it is categorized into drug discovery & development, disease diagnostics, genomics, proteomics, agriculture, and other applications. On the basis of end user, it is classified into biotechnology & pharmaceutical companies, hospitals & diagnostics centers, academic & research institutes, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Benefits for Biochips Market :
The study provides an in-depth analysis of the global biochips market along with current trends and future estimations from 2018 to 2025 to elucidate the imminent investment pockets.
Comprehensive analysis of factors that drive and restrict the market growth is provided.
Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global & regional scale are provided.
Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the market.
Biochips Key market segments :
By Product
DNA Chip
Protein Chip
Lab-on-a-chip
Others
By Application
Drug Discovery & Development
Disease Diagnostics
Genomics
Proteomics
Agriculture
Others
By End User
Biotechnology & Pharmaceutical Companies
Hospitals & Diagnostics Centers
Academic & Research Institutes
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
bioMérieux SA
Bio-Rad Laboratories, Inc.
F. Hoffmann-La Roche AG
Fluidigm Corporation
HORIBA, Ltd.
Illumina, Inc.
PerkinElmer, Inc.
QIAGEN N.V.
Randox Laboratories Ltd.
Thermo Fisher Scientific Inc.
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
Micronit Microfluidics BV
OriGene Technologies, Inc.
ANALIS sa/nv
AMS Alliance
Dynamic Biosensors GmbH
Read the full report: https://www.reportlinker.com/p05663899/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.